Garmin (Venu / Fenix / Forerunner)

Garmin (NASDAQ: GRMN; founded 1989 by Gary Burrell and Min Kao) makes biometric-primary multisport watches such as the Venu 3, Fenix 8, and Forerunner 965 with AI augmentation, recorded in the new biometric form factor. Its devices carry optical heart-rate, blood-oxygen, ECG on select models, and skin-temperature sensors, and layer proprietary analytics including Body Battery, Training Load and Training Readiness, advanced sleep tracking with a Sleep Score and coach, all-day stress, and HRV Status. Its one FDA clearance is the ECG App, cleared via 510(k) K221774 with a decision dated January 12, 2023 and launched on January 24, 2023 on the Venu 2 Plus as Garmin's first FDA-cleared feature for on-demand assessment of signs of atrial fibrillation, later expanded by software to other models. A cap-flag applies because most of Garmin's analytics, including blood oxygen, Body Battery, Training Readiness, stress, and Sleep Score, are wellness features rather than FDA-cleared, with Body Battery in particular a proprietary composite rather than a validated clinical metric, making Garmin lighter on FDA-cleared clinical AI than Apple or Fitbit. Garmin is the purchase-only outlier of the cohort: all core health and training features are free with no required membership, and the newer Garmin Connect+ subscription launched March 27, 2025 at $6.99 a month is optional, adding AI Active Intelligence insights and coaching content without gating existing features, in contrast to subscription-only Whoop and membership-required Oura. Its clinical-validation posture is lighter on cleared clinical AI with strong sensor hardware but proprietary, largely non-peer-validated recovery and training metrics, and the accuracy of Body Battery and Training Readiness and any 2026-model specifics are not verified.

Garmin (Venu / Fenix / Forerunner) is listed at $849 to $1,699 on the DEPLOY registry. This is an actual sale price on record.

Yes. Garmin (Venu / Fenix / Forerunner) is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.

Partly. DEPLOY verifies Garmin (Venu / Fenix / Forerunner) operating autonomously for Tracks fitness and activity and Tracks sleep. Other capabilities (Tracks heart health and Tracks stress and recovery) are only demonstrated under teleoperation or remain vendor claims, not independently verified as autonomous.

Garmin (Venu / Fenix / Forerunner)'s recorded specifications on the DEPLOY registry: Battery: 24 days; Weight: 0.07 kg. See the Specs section for the full sourced set.

Garmin (Venu / Fenix / Forerunner) is made by Garmin, based in Olathe, KS, founded in 1989.

1 verified deployment of Garmin (Venu / Fenix / Forerunner) is on the DEPLOY registry, including at Global.

Garmin (Venu / Fenix / Forerunner) is available for purchase - a real sale price is on record (see the pricing section for the figure and its source).

Garmin (Venu / Fenix / Forerunner) has 2 regulatory records on the DEPLOY registry: FDA 510(k) clearance (K221774), cleared; FDA 510(k) clearance (K221774), cleared. See the Regulatory filings section for each agency source.

On the DEPLOY registry, comparable biometric robots to Garmin (Venu / Fenix / Forerunner) include Blackrock Neuroport Array, BrainQ Non-Invasive BCI, Neko Body Scan, RNS System.

Garmin (Venu / Fenix / Forerunner) and Blackrock Neuroport Array (Blackrock Neurotech · 5 deployments) are both biometric robots on the DEPLOY registry. Garmin (Venu / Fenix / Forerunner) has 1 verified deployment on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.

On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, Garmin (Venu / Fenix / Forerunner) ranks in roughly the top 62% of biometric models tracked by the registry.

Garmin (Venu / Fenix / Forerunner) is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.

Garmin (Venu / Fenix / Forerunner) has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.

Garmin smartwatches track advanced health and fitness metrics including GPS, heart rate, skin temperature, sleep, stress, and sport-specific metrics. Features include a built-in flashlight, bright displays, and wellness tracking. Garmin has FDA-cleared ECG under 510(k) K221774. Known for outdoor and fitness-focused wearables.